Ever Source Wealth Advisors, LLC Acadia Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 968 shares of ACAD stock, worth $19,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
968
Previous 1,685
42.55%
Holding current value
$19,960
Previous $27,000
25.93%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ACAD
# of Institutions
347Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$885 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$315 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$249 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$185 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$127 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.34B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...